newsfilter
← Latest News
GlobeNewswire·

Aravive to Participate in H.C. Wainwright Global Investment Conference

HOUSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today announced that Gail McIntyre, Ph.D, DABT, Chief Executive Officer will pres